Marksans Pharma Share Price
320.15+0.00 (+0.14%)
+78.74% past 1 Year
Corporate filings & documents
Announcements
Notice to Shareholders regarding re-opening of Special Window for Re-lodgement of transfer requests of Physical Shares
3 days agoNotice to Shareholders regarding re-opening of Special Window for Re-lodgement of transfer requests of Physical Shares
3 days agoCopy of Newspaper Publication regarding transfer of unclaimed dividend and equity shares of the Company to the IEPF
1 week agoCopy of Newspaper Publication regarding transfer of unclaimed dividend and equity shares of the Company to the IEPF
1 week agoIntimation of schedule of Investors Meet
2 weeks agoIntimation of schedule of Investors Meet
2 weeks agoPlease find attached the voting result of the 34th AGM
3 weeks agoPlease find attached the voting result of the 34th AGM
3 weeks agoScrutinizers Report along with voting result for the 34th AGM
3 weeks agoScrutinizers Report along with voting result for the 34th AGM
3 weeks agoProceeding of 34th Annual General Meeting of the Company held today
3 weeks agoProceeding of 34th Annual General Meeting of the Company held today
3 weeks agoPlease find attached disclosure on ESG rating
3 weeks agoPlease find attached disclosure on ESG rating
3 weeks agoTranscript of Investors/Analyst meet on Q1 FY 27 Financial Results
1 month agoTranscript of Investors/Analyst meet on Q1 FY 27 Financial Results
1 month agoAudio Recording of investor(s)/analyst(s) meet Conference Call on Q1 FY 27 Financial Results
1 month agoAudio Recording of investor(s)/analyst(s) meet Conference Call on Q1 FY 27 Financial Results
1 month agoNewspaper Publication for Unaudited Financial Results for the quarter ended June 30 2026
1 month agoNewspaper Publication for Unaudited Financial Results for the quarter ended June 30 2026
1 month agoPress Release for Financial Results Q1 FY 27
1 month agoPress Release for Financial Results Q1 FY 27
1 month agoInvestor Presentation Q1 FY 27
1 month agoInvestor Presentation Q1 FY 27
1 month agoThe Board in its meeting held on 12 August 2026 approved Financial Results for the quarter ended June 30 2026
1 month agoThe Board in its meeting held on 12 August 2026 approved Financial Results for the quarter ended June 30 2026
1 month agoThe Board in its meeting held on 12 August 2026 approved the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30 2026
1 month agoThe Board in its meeting held on 12 August 2026 approved the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30 2026
1 month agoPlease find attached newspaper publication for Annual General Meeting Notice
1 month agoPlease find attached newspaper publication for Annual General Meeting Notice
1 month agoPlease find enclosed the BRSR
1 month agoPlease find enclosed the BRSR
1 month agoPlease find attached herewith the Annual Report for the Financial Year 2025-26
1 month agoPlease find attached herewith the Annual Report for the Financial Year 2025-26
1 month agoNotice of the 34th Annual General Meeting of the Company proposed to be held on 27 August 2026
1 month agoNotice of the 34th Annual General Meeting of the Company proposed to be held on 27 August 2026
1 month agoIntimation of schedule for Q1FY27 Earnings Conference Call
1 month agoIntimation of schedule for Q1FY27 Earnings Conference Call
1 month agoMarksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Quarterly Results For The Quarter Ended June 30 2026
1 month agoMarksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Quarterly Results For The Quarter Ended June 30 2026
1 month agoNewspaper Publication for AGM Intimation
1 month agoNewspaper Publication for AGM Intimation
1 month agoUpdate on acquisition of 100 percent share capital of ABCnow GmbH.
2 months agoUpdate on acquisition of 100 percent share capital of ABCnow GmbH.
2 months agoSecond 100 Day Campaign - "Saksham Niveshak" Phase IV
2 months agoSecond 100 Day Campaign - "Saksham Niveshak" Phase IV
2 months agoCertificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026
2 months agoCertificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026
2 months agoMarksans Pharma signed a definitive agreement to acquire 100 percent share capital of a German based Company namely ABCnow GmbH
2 months agoMarksans Pharma signed a definitive agreement to acquire 100 percent share capital of a German based Company namely ABCnow GmbH
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Jun 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation